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Objective: To study the effect of the age of the woman who provides the oocytes 01 who
receives the embryos on results of IVF-ET.
Design: Historical cohort study. Multi vai'iate regression analysis was used to study the ago
effect continuously and after adjustment for confounding.
Setting: Patients of the University of Southern California, Los Angeles, California. 
Patient(s): Couples who underwent standard (n -  277) or donor IVF-ET (n = 294) between
January 1991 and July 1995.
Intervention(s): One cycle of standard or donor IVF-ET.
Main Outcome Measure(s): Successive IVF outcomes from number of oocytes to ongoing 
pregnancy and several measures of pregnancy loss.
Result(s): The number of oocytes decreased with aging of the oocyte provider. More women 
who received oocytes from donors aged 20 to 23 years had at least one good embryo transferred 
than women who received oocytes from older donors. The age of the woman who received the 
embryos had no effect on IVF outcomes. In women > 40 years who underwent standard IVF, 
the probability of pregnancy decreased. No such relationships were observed for donor IVF, but 
all the oocyte donors were younger.
Conclusion(s): An age effect for ongoing pregnancy was only found in women > 40 years 
who underwent standard IVF independent of the lower number of oocytes and suggests decreas­
ing oocyte quality. (Fertil Steril® 1997; 67:702“ 10 © 1997 by American Society for Repro­
ductive Medicine.)
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Diminished fecundity with increasing woman’s 
age is well documented. An increase in anovulatory
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cycles has been found in women after ago 40 years 
(1) and in perimenopausal women wlio experienced 
a sudden break in menstrual cyclicity after years 
of regular cycles (2). Pregnancy rates are known to 
decline with increasing woman's age after artificial 
insemination with donor semen (3-5), after stan­
dard IVF-ET treatment (6-10), and after standard 
IVF-ET using intracytoplasmic sperm injection (11). 
Nevertheless, it is still somewhat controversial 
whether the woman’s age during IVF treatment has 
an effect on oocyte production, oocyte quality, or 
uterine receptivity. Treatment with donor oocytes
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offers a means of studying these effects separately. 
Sauer et al. (12), Abdalla et al. (13), Navot et al. (14), 
and Check et al. (15) found an effect of the woman's 
age on the quality of the oocyte, but no or only a 
negligible effect on uterine receptivity. In more re­
cent studies, Sauer and co-workers (16,17) have con­
firmed that there is no aging effect of the uterus in 
women undergoing donor IVF. However, Levran et 
al. (18), Flamigni et al. (19), Borini et al. (20), and 
Cano et al. (21) found an age effect also on uterine 
receptivity. In the former three studies, the conclu­
sion was based on decreased implantation or preg­
nancy rates in older recipients, whereas Cano et al. 
(21) based their conclusion on increased abortion
rates.
Meldrum (22) suggested that the differences in 
hormone replacement protocols may explain why 
several studies found an aging effect of the uterus 
while others did not. He observed that a dose of 100 
mg/d P administered IM could replenish fully the 
uterine capacity. This effect was corroborated by 
Check et al. (15), who could not find an aging effect 
of the uterus when hormone supplementation was 
prolonged until the endometrium thickness was >10 
mm. However, this factor cannot explain the aging 
effects of the uterus found by Flamigni et al. (19), 
Cano et al. (21), and Borini et al. (20), whose patients 
were all supplemented with high doses of P. More­
over, Meldrum (22) suggested that the low rate of 
spontaneous abortions observed in older women 
after donor IVF could be explained by the corrective 
effect of the hormone replacement. However, Cano 
et al. (21) used high doses of P and found an in­
creased rate of spontaneous abortion in women of 
>40 years.
Other explanations for the controversy in results 
between studies might be found in the characteris­
tics of the population and the methods used for anal­
ysis. Most of the studies that used data from donor 
IVF (12, 14,15, 17,18, 20-22) only examined differ­
ences in IVF results between two age groups. Ex­
isting age effects might have been missed because 
the chosen cutoff point did not maximize the differ­
ences between the two age groups. Also, the range 
in age might have been too small to detect an effect. 
Moreover, often no adjustment was made for the con­
founding effects of factors, such as type of infertility 
and man's age.
In this study, we addressed the question of 
whether there is an effect of the woman's age on IVF 
outcomes by using a data base containing a wide age 
range of women who provided oocytes and women 
who received the embryos. Multivariate regression 
analysis was used to account fully for the age of the 
oocyte providers and recipients and to account fully 
for any potential confounding effects.
MATERIALS AND METHODS
To study the effect of the woman’s age on IVF 
results, data were used from patients who under­
went standard or donor IVF at the University of 
Southern California, Los Angeles, California, be­
tween January 1991 and July 1995. Before accep­
tance for donor IVF, the women were screened to 
ensure that they were in good health (23). A normal 
uterine cavity was documented in all patients by a 
normal hysterosalpingogram or prior hysteroscopy. 
Additionally, all recipients underwent a “mock cycle" 
of steroid replacement with an endometrial biopsy, 
indicating appropriate histologic response to the reg­
imen. The protocol for ovarian hyperstimulation in 
the oocyte donor women was the same as that in the 
women who underwent standard IVF. Most women 
received a long protocol of GnRH agonist, started at 
the midluteal phase of the previous cycle, and hMG. 
Hormone supplementation of the oocyte recipients 
consisted of oral E2, starting approximately 3 days 
before the donor’s initiation of hMG treatment. Pro­
gesterone supplementation was started on the morn­
ing after hCG had been administered to the donor. 
On the first day of P supplementation, the recipient 
received 50 mg of P IM followed by 100 mg daily. 
Pregnancies were supported by E2 and 100 mg P 
daily until 100 days after ET. The women who un­
derwent standard IVF received 25 mg P IM daily 
commencing on the day of ET and continuing until 
approximately 9 weeks of gestation. These protocols 
have been described more extensively by Paulson et 
al. (24).
Only the data from IVF cycles using controlled 
ovarian hyperstimulation were included. We ex­
cluded any cycles in which intracytoplasmic sperm 
injection had been performed and all those in which 
there was no male partner. Data from women who 
underwent standard IVF were used only if follicle 
aspiration had been performed. To prevent bias be­
cause of repeated cycles after unsuccessful treat­
ment, only the first IVF treatment cycle of each 
woman was analyzed. If donor IVF had been per­
formed after standard IVF, only the donor IVF cycle 
was included in the analyses. Information on cryo- 
preserved ET was disregarded. A total of 571 couples 
met the criteria for inclusion: 277 women underwent 
standard IVF and 294 underwent donor IVF. All the 
oocytes retrieved after one controlled ovarian hyper­
stimulation cycle in a donor woman were donated to 
only one recipient. Each donor woman could give 
more than one donation. None of the oocyte donors 
underwent IVF treatment themselves. Characteris­
tics of the couples are given in Table 1. The age 
distribution is shown in Figure 1.
The following outcomes were recorded from each
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Table 1 C haracteristics of the Couples Who U nderw ent 
S tandard  IVF or Donor IVF
Standard IVF Donor IVF
Characteristic (n -  277) (n = 294)
■^S®i>rovidiT )
24 to 45 20 to 37Range
Median 36 30
Mean ± SD 35.4 ± 4,5 29.2 ± 4.0
Missing 0 34
Ager<,Cipjent (y)
24 to 59Range 24 to 45
Median 36 43
Mean ± SD 35.4 ± 4.9 42.2 ± 6.2
Missing 0 0
Man’s age (y)
24 to 74Range 23 to 66
Median 38 42
Mean ± SD 37.5 ± 6.3 42.2 ± 7.9
Missing 22 20
Infertility factor woman*
0 (0.0)Tubal pathology 126 (49.8)
Endometriosis 27 (10.7) 0 (0.0)
Transitional menopause! 0 (0.0) 160 (55.7)
Menopause* 0 (0.0) 111 (38.7)
Genetic 0 (0.0) 9 (3.1)
Chemotherapy 0 (0.0) 7 (2.4)
None§ 100 (39.5) 0 (0.0)
Missing 24 7
Male infertility factor 90 (34.2) 113 (40.7)
Missing 14 14
Use of donor sperm 25 (9.1) 33 (11.2)
Missing 2 0
Long GnRH agonist ovarian
stimulation protocol 237 (89.4) 271 (94.5)
Missing 12 10
* Values in parentheses are percentages, 
t Including previous IVF failure and elevated basal FSH levels. 
t  Including premature ovarian failure and castration.
§ Including unexplained infertility (n = 46) and male factor 
infertility only (n = 49). (For five couples missing information on 
male factor).
aspiration cycle: number of oocytes retrieved, num­
ber of fertilized oocytes (counted 1 day after insemi­
nation), number of transferred embryos of good qual­
ity (at 48 hours after insemination: even blastomeres 
and <10% fragmentation if less than six blasto­
meres or <25% fragmentation if six or more blasto­
meres), positive pregnancy test result, clinical preg­
nancy (one or more gestational sacs observed by 
ultrasound), and ongoing pregnancy (>12 weeks 
after ET). In addition, the occurrence of no implanta­
tion after ET, pregnancy loss (within 12 weeks after 
ET) after a positive pregnancy test result, and spon­
taneous abortion (within 12 weeks after ET) after a
clinical pregnancy were studied in relation to the 
woman’s age.
The impact of age was studied in three phases. 
Phase I: the relationships with the age of the woman 
who provided the oocytes (ageprovider) and the number 
of oocytes, fertilized oocytes, and number of good 
quality embryos transferred were studied for stan­
dard and donor TVF separately. Phase II. the effect 
of the age of the woman who received the embryos 
(agerecipient) on IVF outcomes after ET was studied. 
OwingTo the fact that each woman who underwent 
standard IVF was both the oocyte provider and em­
bryo receiver, it could not be determined whether a 
correlation between agerecipumt &nd implantation or 
pregnancy outcome was due to oocyte or uterus fac­
tors. Therefore, the associations between ageVCC|p^un^ 
and implantation and pregnancy outcome data were 
examined only in donor IVF. Phase III: if such an 
association with agerecipicmt exists, the relationships 
of ageprovider with treatment outcomes after ET only 
can be studied in women who undergo donor IVF. 
If there is no relationship with aget.0CiPj0n{;> it can be 
assumed that there is no aging effect of the uterus 
in standard IVF as well. In that case, information 
from both standard and donor IVF can be used to 
investigate whether there remains an effect of the 
ageproVider on ^ e  outcomes of IVF after ET.
Linear regression was used if the dependent vari­
able had a continuous distribution, whereas logistic 
regression analysis was used if the dependent vari­
able was dichotomous. Results of logistic regression 
analysis are presented in the form of odds ratios 
(OR) with 95% confidence intervals (Cl). To study 
whether the relationship between the IVF result and 
the woman’s age showed a change in trend, catego­
ries were made for each 5 years of age if the number 
of couples in the age group was reasonably large. As 
a reference category, the age group with the largest 
number of couples was chosen. When a change in age 
trend was suspected on the basis of the regression 
coefficients of these categories, we performed several 
regression analysis to locate the best cutoff point, 
which allowed for a change in the continuous age
Number of women
55 59
Age of the woman (years)
Figure 1 Age distribution of the oocytc donors, oocyte recipi 
ents3 and women who underwent standard IVF.
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effect. The best cutoff point was selected by choosing 
the model with the highest explained variation in 
IVF result by age as expressed by the F -test or the 
likelihood ratio test -21n(Li/L2).
An association between the woman’s age and the 
outcome of IVF can be confounded by the effects of 
several factors. Confounding can be detected by ob­
serving a substantial change in the regression coef­
ficients of the age variables after adjustment for con­
founding. To adjust for confounding, all the potential 
confounders were included into the linear or logistic 
regression model as dummy variables. For the num­
ber of oocytes retrieved, potential confounding fac­
tors were the type of hormonal ovulation stimulation 
(long protocol of GnRH agonist versus others) and, 
only for standard IVF, type of infertility of the 
woman who provided the oocytes (tubal pathology, 
endometriosis, or none). For the relationships with 
fertilized oocytes and the number of good quality 
embryos transferred, potential confounders included 
also a male infertility factor and the age of the male 
partner. For the other IVF results, additional poten­
tial confounders were the type of infertility of the 
embryo recipient (for standard IVF: tubal pathology, 
endometriosis, or none; for donor IVF: transitional 
menopause, menopause, chemotherapy, or genetic). 
For a description of the definitions of the types of 
infertility in women, see Sauer et al. (16). Male infer­
tility factor was defined as abnormal semen analysis, 
vasectomy reversal, failed hamster test, or prior 
failed fertilization. If donor sperm was used, a male 
infertility factor was considered to be absent. 
Dummy variables of 5-year groups were constructed 
for male age, which provided the possibility of in­
cluding a dummy variable for male age if donor 
sperm was used.
RESULTS
The IVF results of the couples who underwent 
standard or donor IVF are shown in Table 2. No 
oocytes were retrieved after follicle aspiration in one 
woman who underwent standard IVF and in one do­
nor woman. No fertilization occurred in another 19 
couples with standard IVF and in 13 couples with 
donor IVF. Additionally, no embryos were trans­
ferred in another five women with standard IVF and 
two women with donor IVF. In three women with 
standard IVF, all the embryos were frozen.
The results of the effects of agepr0Vider and agerecipient 
are shown in Tables 3 and 4. As confounding was 
present in many instances, only the adjusted results 
are shown for the analyses with 5-year age groups. 
If a change in age effect by using a cutoff point ex­
plained the variation in IVF outcomes better than a 
continuous age effect (as presented in Tables 3 and
Vol. 67, No. 4, April 1997
Table 2 In Vitro Fertilization Outcomes of the Couples Who 
Underwent Standard IVF or Donor IVF
In vitro fertilization outcome
Standard 
IVF 
(n -  277)
Donor 
IVF 
(n = 294)
No. of oocytes/aspiration
Range Oto 57 Oto 58
Median 12 15
Mean ± SD 13.1 ± 8.2 16.4 ± 7.8
Missing 0 0
No. of fertilized oocytes/aspiration
Range 0 to 31 0 to 24
Median 5 7
Mean ± SD 6.3 ± 4.9 8.0 ± 4.8
Missing 0 0
No. of transferred embryos/aspiration*
Range 0 to 8 0 to 9
Median 5 5
Mean ± SD 3.8 ± 1.8 4.3 ± 1.5
Missing 0 0
No. of good embryos transferred/aspiration*
Range Oto 5 Oto 5
Median 0 0
Mean ± SD 0.6 ± 1.0 0.5 ± 0.8
Missing 0 0
No. of embryos implanted/aspiration*
Range 0 to 3 Oto 5
Median 0 0
Mean ± SD 0.4 ± 0.8 0.6 ± 1.0
Missing 14 5
Percent embryos implanted/ETf
Range 0 to 100 0 to 100
Median 0 0
Mean ± SD 9.1 ± 18.2 13.4 ± 21.9
Missing 14 5
One or more good embryo transferred/
aspiration* 91 (33.2)$ 90 (30.6)
Missing 0 0
Positive pregnancy test result/aspiration* 83 (30.9) 109 (37.2)
Missing 5 1
Clinical pregnancy/aspiration”1 70 (26.0) 102 (34.8)
Missing 5 1
Ongoing pregnancy/aspiration* 62 (23.0) 81 (27.6)
Missing 5 1
No implantation/ETf 117 (74.4) 175 (64.1)
Missing 14 5
Pregnancy loss/positive pregnancy test result§ 21 (25.3) 28 (25.7)
Missing 5 1
Spontaneous abortion/clinical pregnancy|| 8 (11.4) 21 (20.6)
Missing 5 1
* Excluding three women with all embryos frozen after standard IVF.
f Excluding 25 and 16 women without ET, respectively, for standard and 
donor IVF.
$ Values in parentheses are percentages.
§ Excluding 189 and 184 women without a positive pregnancy test result, 
respectively, for standard and donor IVF.
|| Excluding 202 and 191 women without a clinical pregnancy, respec­
tively, for standard and donor IVF.
4), the regression coefficients or ORs accompanying 
the lines before and after the cutoff point are pre­
sented in the text. They are not shown in Tables 3 
and 4. To calculate percentages of women who had 
a specific IVF outcome, the most common distribu­
tion of confounders was assumed: tubal factor for 
standard IVF and transitional menopause for donor 
IVF, a long protocol of GnRH agonist, no male infer­
tility factor, no donor sperm, and male age of 38 
years for standard IVF and 42 years for donor IVF.
Phase I: Ageprovider and IVF Outcomes Before ET
Both in standard IVF and in donor IVF, the num­
ber of oocytes decreased steadily with increasing age
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Table 3 Regression Coefficients (0) of Linear Regression Analysis for Crude and Adjusted Associations* Between the Woman’s 
Age From Whom the Oocytes are Retrieved (agepr0Vider) and to Whom the Embryos are Transferred (agerccipient) and IVF Outcomes 
for Standard and Donor IVF Separately
»
In vitro fertilization 
outcome
A. Standard IVF and age (n = 277)t B. Donor IVF and ageprovider (n = 260)
Crude Adjusted
In categories (y) adjusted$§
Crude Adjusted
In categories (y) adjusted^
24 to 29 30 to 34 40 to 45 20 to 24 25 to 29 35 to 37
No. of oocytes retrieved/
aspiration
P -0.51 -0.47 6.25 0.79 -1.11 -0.29 -0.24 2.16 0.83 - 0.86
SE (/?) 0.11 0.11 1.74 1.20 1.45 0.12 0.12 1.37 1.14 2.00
n 277 245 245 260 253 253
P 0.0001 0.0001 0.002 0.01 0.05 0.38
No. of oocytes fertilized/
aspiration
P -0.16 -0.04 1.50 -0.37 1.14 -0.14 -0.04 1.40 0.04 3.27
SE C/3) 0.07 0.08 1.17 0.78 0.97 0.07 0.08 0.88 0.74 1.47
n 277 225 225 260 227 227
P 0.01 0.64 0.27 0.06 0.61 0.07
* Variables adjusted for were, for number of oocytes retrieved: 
type of hormonal ovulation stimulation and, only for standard 
IVF, type of infertility of the woman who provided the oocytes; 
for fertilized oocytes: additionally, male infertility factor and 
man’s age.
t  For standard IVF agepn)Vit|Dr = agerecipient.
t  P values in this column refer to the variation in IVF result 
explained by age as expressed in the F  test; n refers to the sample 
size.
§ Reference category: 35 to 39 years.
U Reference category: 30 to 34 years.
of the woman who provided the oocytes (Table 3, Cl 0.92 to 1.10). All the women who underwent stan- 
columns A and B). For standard IVF, this association dard IVF were >23 years, 
was best described CF2>239 = 11.02, P  = 0.0001) by a
model that allowed for a rapid decrease before the Phase II: AgereciPient and IVF Outcomes After ET 
age of 32 years [ft = -1.25, SE(/?) = 0.38], followed
by a slower decrease thereafter [/? 0.19, SE(/3)
= 0.17]. In Figure 2, data are shown from the women 
who underwent standard IVF because of tubal pa­
thology, who received a long GnRH agonist ovarian 
stimulation protocol. Both the accompanying regres­
sion lines are presented in Figure 2, one using no 
cutoff point, and the better-fitting one, which used 
a cutoff point at 32 years. For donor IVF, the number 
of oocytes donated by women aged 20 to 37 years 
decreased steadily by 0.24 oocyte per year.
The number of fertilized oocytes seemed to be re-
Next, analyses were performed to study whether 
the age of the women who received the embryos from 
donor IVF was related to pregnancy outcome. No 
association was found between agereCiPient and the 
probability of a positive pregnancy test result, clini­
cal pregnancy, ongoing pregnancy, implantation, 
pregnancy loss, and spontaneous abortion (Table 4, 
column C).
Phase III: Agepr0vider and IVF Outcomes After ET
As the aging effect of the recipient seemed to be
lated negatively to the age of the woman who pro- negligible, the question remained as to whether the 
vided the oocytes. However, this association disap- age of the oocyte provider affected these six preg- 
peared after adjustment for confounding (Table 3, 
columns A and B).
nancy outcome parameters. On the basis of these 
data on donor IVF, it was assumed that there would
In standard IVF, the transfer of at least one good be no effect of an aging uterus either in women who 
quality embryo was not related to the age of the underwent standard IVF. This provided the opportu­
nity to study the effect of ageprovider using data from 
both standard and donor IVF1. The results of the
woman who provided the oocytes (Table 4, column 
A). In donor IVF, a change in age effect best ex­
plained the variation in this IVF outcome (-21n[L1/ 
L2] = 11.49, df = 2, P = 0.003). At least one good 
embryo was transferred in 78% and 52% of the
analyses on agepr0Vider are shown in columns A and 
B of Table 4.
In standard and donor IVF, a positive pregnancy
women who received oocytes from donors of 21 and test result was not related to the age of the woman
22 years, respectively (OR = 0.32, 95% Cl 0.15 to who provided the oocytes. After adjusting for con-
0.70). This occurred in only approximately 27% of founding effects and after allowing for a change in
those with ageproVider of —23 years (OR = 1.01, 95% trend, the probability of clinical pregnancy, as well
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Table 4 Odds Ratios and 95% Confidence Intervals for Crude and Adjusted Associations* Between the Woman’s Age From Whom the Oocytes are Retrieved (ageprovider) 
and to Whom the Embryos are Transferred (agerecipient) and IVF Outcomes for Standard and Donor IVF Separately
A. Standard IVF and age.(n = 277)t B. Donor IVF and agep^d«,,. (n = 260) C. Donor IVF and age^^m  (n = 294)
In vitro In categories (y) adjusted^ In categories (y) adjusted*!! In categories (y) adjusted^
fertilization
outcome Crude Adjusted 24 to 29 30 to 34 40 to 45 Crude Adjusted 20 to 24 25 to 29 35 to 37 Crude Adjusted 24 to 34 35 to 39 45 to 49 50 to 59
0.98 
0.93 to 1.04 
274 
0.54
1.06 
0.97 to 1.15 
222 
0.18
1.16
0.40 to 3.38
0.82 
0.39 to 1.71 
222 
0.33
2.19 
0.82 to 5.86
0.95 
0.89 to 1.02 
260 
0.14
0.94 
0.87 to 1.01 
227 
0.08
1.98 
0.91 to 4.31
0.97 
0.48 to 1.94 
227 
0.31
1.37 
0.36 to 5.17
0.99 
0.93 to 1.05 
269 
0.63
0.97 
0.89 to 1.06 
217
0.52 
0.14 to 1.90
1.55 
0.75 to 3.19 
217 
0.15
0.55 
0.19 to 1.60
0.99 
0.93 to 1.06 
260 
0.78
0.98 
0.91 to 1.05 
227 
0.50
1.82 
0.83 to 3.99
0.88 
0.45 to 1.73 
227 
0.27
1.90 
0.52 to 6.91
1.01 
0.97 to 1.04 
293 
0.72
1 . 0 1  
0.96 to 1.06 
252 
0.69
0.95 
0.29 to 3.10
0.59 
0.23 to 1.47 
252 
0.80
1.01 
0.48 to 2.13
0.85 
0.31 to 2.30
0.96 
0.91 to 1.03 
269 
0.25
0.95 
0.88 to 1.04 
217 
0.29
0.47 
0.12 to 1.87
1.49 
0.71 to 3.11 
217 
0 . 1 1
0.47 
0.15 to 1.44
0.99 
0.93 to 1.05 
260 
0.66
0.98 
0.91 to 1.06 
227 
0.63
1.79 
0.81 to 3.96
0.90 
0.45 to 1.79 
227 
0.22
2.49 
0.67 to 9.29
1.02 
0.98 to 1.06 
293 
0.37
1.01 
0.96 to 1.07 
252 
0.63
1.04 
0.31 to 3.47
0.59 
0.23 to 1.52 
252 
0.70
1.20 
0.56 to 2.56
0.94 
0.34 to 2.59
0.96 
0.90 to 1.02 
269 
0.18
0.96 
0.87 to 1.05 
217 
0.32
0.56 
0.13 to 2.30
1.70 
0.78 to 3.68 
217 
0.09
0.43 
0.13 to 1.42
1 . 0 0  
0.94 to 1.07 
260 
0.97
1 . 0 0  
0.92 to 1.08 
227 
0.95
1.21 
0.51 to 2.89
0.93 
0.44 to 1.96 
227 
0.65
2.21 
0.57 to 8.47
1.01 
0.97 to 1.05 
293 
0.69
1 . 0 0  
0.94 to 1.06 
252 
0.92
1.08 
0.29 to 4.03
0.63 
0.22 to 1.78 
252 
0.88
0.88 0.74
0.38 to 2.00 0.24 to 2.21
1.07 
1.00 to 1.14 
238 
0.06
1.09 
1.00 to 1.20 
196 
0.06
1.41 
0.33 to 6.04
0.47 
0.21 to 1.05 
196 
0.05
2.17 
0.68 to 6.96
1 . 0 0  
0.94 to 1.07 
244 
0.89
1.01 
0.94 to 1.09 
215 
0.73
0.61 
0.27 to 1.35
1.19 
0.59 to 2.42 
215 
0.29
0.46 
0.12 to 1.70
0.98 
0.95 to 1.02 
237 
0.44
0.99 
0.94 to 1.05 
236 
0.70
0.76 
0.20 to 2.91
1.41 
0.54 to 3.69 
236 
0.75
0.76 
0.35 to 1.65
0.94 
0.33 to 2.65
1.11 
0.97 to 1.27 
76 
0.12
1.07 
0.89 to 1.28 
69 
0.46
0.74 
0.05 to 10.17
0.70 
0.17 to 2.93 
69 
0.75
2.71 
0.31 to 23.79
0.97 
0.87 to 1.09 
86 
0.61
0.99 
0.87 to 1.13 
76 
0.92
1.81 
0.47 to 7.03
0.64 
0.15 to 2.75 
76 
0.64
1.47 
0.11 to 19.47
1 . 0 0  • 
0.93 to 1.07 
96 
0.97
1.03 
0.94 to 1.13 
85 
0.53
0.65 
0.06 to 6.52
0.87 
0.15 to 5.11 
85 
0.97
1.18 1.18 
0.31 to 4.51 0.19 to 7.45
1.08 1.01 G.48§§ 
n 07 In 3.28
0.96 0.99 2.11 0.87 1.88 1.02 1.05 0.63 0.81 1.68 1.75
0.85 to 1.08 0.86 to 1.14 0.50 to 8.83 0.19 to 3.90 0.14 to 25.35 0.95 to 1.10 0.95 to 1.16 0.05 to 8.35 0.11 to 6.18 0.42 to 6.75 0.25 to 12.25
At least one good 
embryo 
transferred/ 
aspiration**
OR
95% Cl 
n 
P
Positive
pregnancy 
test result/ 
aspiration**
OR
95% Cl 
n
P
Clinical
pregnancy/ 
aspiration**
OR
95% Cl
n 
P
Ongoing
pregnancy/ 
aspiration**
OR
95% Cl
n
P
No implantation/
ETft 
OR
95% Cl
n 
P
Pregnancy loss/ 
positive 
pregnancy
test#
OR
95% CJ
n
P
Spontaneous 
abortion/ 
clinical 
pregnancyl
OR
95% Cl   _______
n 65 59 59 83 73
P  0.47 0.97 0.45 0.48 0.88
* Variables adjusted for were for number of good quality embryos transferred: type of hormonal ovulation stimula­
tion, male infertility factor, man’s age, and, only for standard IVF, type of infertility of the woman who provided the 
oocytes; for the other IVF results: additionally, type of infertility of the embryo recipient.
t  For standard IVF ageprovidcr = agerocipi<!nt.
$ P  values in this column refer to the variation in IVF result explained by age as expressed in the likelihood ratio 
test; n refers to the sample size.
§ Reference category: 35 to 39 years (OR = 1).
73 92 81 81
0.68 0.65 0.31 0.85
¡1 Reference category: 30 to 34 years (OR = 1).
Reference category: 40 to 44 years (OR -  1).
** Excluding three women with all embryos frozen after standard IVF. 
t t  Excluding 25 and 16 women without ET, respectively, for standard and donor IVF.
±± Excluding 189 and 184 women without a positive pregnancy test result, respectively, for standard and donor IVF. 
§§ Age group 20 to 34 versus ^35 years.
||[| Excluding 202 and 191 women without a clinical pregnancy, respectively, for standard and donor IVF.
Number of oocytes
60 
50
40
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20
10
24 26 28 30 32 34 36 38 40 42 44
Age of women undergoing standard IVF (years)
Figure 2 Number of oocytes per age of women who underwent 
standard IVF because of tubal pathology and who received a long 
GnRH agonist ovulation stimulation protocol, and regression 
lines with and without cutoff point.
as the probability of ongoing’ pregnancy after stan­
dard IVF, only decreased steadily when the age of 
the oocyte provider exceeded 40 years. (For clinical 
pregnancy until age 40 years: OR = 1.01, 95% Cl 
0.92 to 1.12; after age 40 years: OR = 0.30, 95% Cl 
0.10 to 0.87; -21n[Li/L2] = 10.37, df = 2, P = 0.006. 
For ongoing pregnancy until age 40 years: OR 
= 1.01, 95% Cl 0.91 to 1.12; after age 40 years: OR 
= 0.32, 95% Cl 0.11 to 0.91; -21n[L1/L2] = 9.00, df 
= 2, P -  0.01). The probabilities of clinical preg­
nancy and ongoing pregnancy were 25% to 29% and 
20% to 23% between the ages of 24 to 40 years, re­
spectively. These probabilities decreased rapidly 
after age 40 years to 11% and 9%, respectively, and 
were even lower at higher ages. In donor IVF the 
agGprovider ^id not affect the probability of achieving 
a clinical or an ongoing pregnancy, but the women 
who donated the oocytes were ^37 years.
The probability of no implantation after ET in 
standard IVF increased with increasing woman’s 
age (Table 4, column A). With higher age of the oo­
cyte provider, more often no implantation occurred. 
The variation in implantation was best explained by 
a logistic regression model that allowed for a change 
in trend after age 40 years (after adjustment for con­
founding effects: until age 40 years: OR = 1.03, 95% 
Cl 0.93 to 1.14; after age 40 years: OR = 3.47, 95% 
Cl 1.19 to 10.14; ~21n[L1/L2] = 12,32, df = 2, P 
= 0.002). This resulted in a probability of no implan­
tation that increased slightly from 70% at age 24 
years to 79% at age 40 years. This probability in­
creased drastically after age 40 years to 93% at age 
41 years and higher at older age. Similar to the ab­
sence of an ageprovicIer effect on the probability of 
achieving a clinical or an ongoing pregnancy in donor
IVF, no age effect was found on implantation in 
women who underwent donor IVF (Table 4, column 
B), because all the women who provided oocytes were 
<40 years. In women who underwent standard or 
donor IVF, no ageprovider trend was apparent for the 
occurrence of pregnancy loss after a positive preg­
nancy test or for the probability of spontaneous abor­
tion after a clinical pregnancy (Table 4, columns A
and B),
DISCUSSION
Several studies have addressed the effect of wom­
an’s age on the success of IVF treatment with do­
nated oocytes (e.g., Sauer et a l [12, 16], Abdalla et 
al. [13], Flamigni et al. [19]; Navot et al. [14]; Check 
et al, [15]; Cano et al. [21]; Borini et al. [20]). The 
results were contradictory. The influence of con­
founding factors, the use of arbitrary cutoff points, 
small numbers of women under study, and a narrow 
age range might have caused the disagreement. 
Therefore, we performed this study. We used an ex­
tended data base of the donor IVF cycles described 
by Sauer et al. (12, 16) and Legro et al. (17). In 
contrast with these previous reports and reports by 
others, we studied the age effect continuously, ad­
justed for confounding effects, and used only the first 
IVF treatment cycle to prevent bias from repeated 
cycles after a failed treatment cycle.
Although the data base used in this study con­
tained a relatively large number of couples who un­
derwent standard or donor IVF, the number still 
might be too small to demonstrate statistically sig­
nificant age effects. Therefore, we did not interpret 
the P values too rigidly and we attached more impor­
tance to the values and the directions of the regres-
*
sion coefficients.
The importance of adjusting for confounding is il­
lustrated by the results found for fertilized oocytes. 
The number of fertilized oocytes was related to the 
agepv0vider only when no adjustment was made for the 
effects of the stimulation protocol, infertility factor 
of the women who underwent standard IVF, type of 
IVF, male infertility factor, and male age. Thus, the 
relationship between the number of fertilized oo­
cytes and ageprovider could be explained by the un­
equal distribution of the confounding factors over 
ag6Provider‘ Although we presume that we were able to 
adjust for confounding effects of the most important 
confounders, there might have been residual con­
founding. Examples of such factors might have been 
the number of ovaries and the basal FSH levels of 
the oocyte providers. Unfortunately, this informa­
tion was not available.
We categorized the women according to age only 
to see whether there was a change in age effect.
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Where appropriate, we used the age distribution on 
a continuous scale to describe the age effect and al­
lowed for a change in age effect by incorporating a 
cutoff point. Some changes in the age effect were 
found at a certain age in the women who underwent 
standard IVF. The number of oocytes retrieved de­
clined rapidly by 1.25 oocytes per year between 24 
and 32 years of age and by only 0.19 oocyte per year 
after the age of 32 years. In the women who under­
went standard IVF, the probability of achieving a 
clinical or an ongoing pregnancy per aspiration de­
creased and the probability of no implantation after 
ET increased sharply after the age of 40 years. Al­
though the model provided the best explanation for 
the variation in IVF results at the specific cutoff 
points, models that used cutoff points of 1 year 
higher or lower also were reasonably accurate. 
Therefore, these cutoff points should not be consid­
ered too strictly. The authors of a recent study on 
standard IVF reported that they could not demon­
strate a change in age effect (25). However, as they 
included age only as a (log)linear variable in the 
model, it was not possible (by definition) to find a 
change in trend. In other studies, changes in the age 
effect were reported. A decline of approximately 12% 
per year in the probability of conception after treat­
ment with artificial insemination with donor semen 
only occurred after the age of 31 years (5). This can­
not be compared directly with our age effect results, 
because of the difference in treatment, especially the 
ovarian hyperstimulation. For example, it is possible 
that controlled ovarian hyperstimulation delays the 
appearance of this age effect, Two studies on stan­
dard IVF found a gradual decrease in positive preg­
nancy test results or ultrasound evidence of a gesta­
tional sac and live birth rates after the age of 34 
years (9) and a steeper decline in the pregnancy rate 
after the age of 37 years than before the age of 37 
years (7).
Although the age of the oocyte provider was re­
lated negatively to the number of oocytes retrieved, 
there was no effect on the occurrence of a positive 
pregnancy test. A decrease in the ultimate aim of 
IVF treatment, to achieve an ongoing pregnancy, 
only occurred after the oocyte provider had reached 
40 years of age. This also was reflected by the lack 
of implantation after ET and no clinical pregnancy. 
These effects only were found in the women who 
underwent standard IVF, but not in donor IVF. This 
might be explained by the age distribution of the 
oocyte donors: they were all younger than 38 years. 
Such findings might indicate an aging affect of the 
oocytes, but we consider the possibility that the ef­
fects were due to a decrease in the number of oocytes 
with age, without any loss of oocyte quality in older 
women. To determine whether this hypothesis holds,
we studied, in couples without male infertility factor 
who underwent standard IVF, whether the occur­
rence of an ongoing pregnancy still was related to the 
ageProvider after controlling for the number of oocytes 
retrieved in addition to adjusting for the confound­
ing factors. There was still a decrease in the proba­
bility of achieving an ongoing pregnancy after the 
age of 40 years (until age 40 years: OR = 1.02, 95% 
Cl 0.90 to 1.15; after age 40 years: OR = 0.31, 95% 
Cl 0.11 to 0.89; -2hi[L /L2] = 9.03, df = 2,P = 0.01). 
Moreover, the amount of variation in the occurrence 
of an ongoing pregnancy that could be explained by 
age provider was similar in the model which included 
the number of oocytes and in the model that ex­
cluded the number of oocytes in couples without a 
male infertility factor (-21n[Li/L2] = 8.85, df = 2, P 
= 0.01). Thus, the effect of agepr0Vjder was not caused 
by the number of oocytes retrieved.
A larger proportion of the women who received 
oocytes from donors aged 20 to 23 years had at least 
one good quality embryo transferred than those who 
received oocytes from older women. This age effect 
was not found in standard IVF and might be ex­
plained by the age distribution of the women who 
underwent standard IVF: all the women were >24 
years. This seems to indicate that, the younger the 
oocyte donor, the more oocytes that will be retrieved 
and the higher the probability that at least one good 
quality embryo will be transferred. When we exam­
ined this in couples without a male infertility factor 
who underwent donor IVF, the observed relationship 
still remained after controlling for the number of 
oocytes (until age 23 years: OR = 0.28, 95% Cl 0.11 
to 0.68; after age 23 years: OR = 1.01, 95% Cl 0.90 
to 1.13; -21n[L/L2] = 12.78, df = 2, P = 0.002].
The quality of the oocytes from young oocyte donors 
seemed to be better than that from older donors. 
This study shows that there is no aging effect of the 
uterus, but that there is an aging effect of the oocyte 
in women of >40 years.
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